• SENSEX
    NIFTY 50
Business

AbbVie makes $63 billion bid for Botox maker Allergan

Updated : June 26, 2019 05:16 PM IST

AbbVie has repeatedly hiked Humira's monthly list price, from $1,524 in 2009 to $5,174 this year, to squeeze extra billions from it.
Humira, which treats rheumatoid arthritis, psoriasis and colitis, saw sales slip in the first quarter due to growing biosimilar competition overseas.
Humira, which treats rheumatoid arthritis, psoriasis and colitis, saw sales slip in the first quarter due to growing biosimilar competition overseas.
AbbVie makes $63 billion bid for Botox maker Allergan

You May Also Like

Live TV
Advertisement